This study indicated that both serum and intestinal mucosal lncRNA-MIR3142HG, alone or combined with fecal calprotectin, may be useful for evaluating clinical and endoscopic activity in pediatric CD, with combined assessments yielding superior efficacy.
Qiao et al. (Mon,) studied this question.